Drugs / Norco
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | NORCO | — | 1997-02-14 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03447353 | Jun → Oct 2016 | — | Timothy L. Brown | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 3 | NCT04872322 Comparator | Aug 2017 → Dec 2021 | — | Rothman Institute Orthopaedics | Unknown | No outcome recorded |
| Phase 3 | NCT02381132 Comparator | Nov 2014 → Dec 2015 | — | Neil Singla | Terminated | No outcome recorded |
| Phase 4 | NCT07195669 Comparator | Oct → Dec 2025 overdue | — | Jacob Lensing | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06113211 Comparator | Oct 2024 → Sep 2026 overdue | disease of bone structure, substance-related disorder | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT03872843 Comparator | Sep 2019 → Feb 2020 | nephrolithiasis | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03858231 Comparator | Oct 2018 → Dec 2027 expected | neuropathy, painful, osteoarthritis, knee, substance-related disorder | Sanford Health | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norco | “The traditional narcotic intervention is: 60 pills of Norco 5-325 q4 hours PRN.” NCT06113211 ↗ |
| Route | Oral | “oral MNK155 and Norco® 7.5mg/325mg” NCT02381132 ↗ |